William Lewis - Jan 4, 2024 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ William Lewis
Stock symbol
NAMS
Transactions as of
Jan 4, 2024
Transactions value $
$0
Form type
3
Date filed
1/8/2024, 07:40 PM
Previous filing
Oct 31, 2023
Next filing
Jan 10, 2024

No securities are beneficially owned.